ConvergEx Upgrades MillenniumSM ATS

A view of downtown Manhattan in New York
ConvergEx operates two ATSs, Millennium and VortEx.

The upgrades are designed to support ultra-low latency, and include matching engine optimization and connectivity advancements. The firm says it is currently in the process of transitioning customers onto its new FIX architecture.

"Millennium is known for its pioneering role in dark-pool execution, diverse liquidity and high execution quality," says Brian Carr, managing director and co-head of sell-side services at ConvergEx Execution Solutions. "This upgrade continues Millennium's long established tradition of excellence and keeps customers at the forefront of execution technology."

According to ConvergEx, Millennium is one of the industry's most comprehensive continuous ATSs in the US equity market, aggregating more than five billion shares of available liquidity in over 6,000 symbols daily. Over 100 broker-dealers access the Millennium ATS every day.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Enough with the ‘Bloomberg Killers’ already

Waters Wrap: Anthony interviews LSEG’s Dean Berry about the Workspace platform, and provides his own thoughts on how that platform and the Terminal have been portrayed over the last few months.

Banks seemingly build more than buy, but why?

Waters Wrap: A new report states that banks are increasingly enticed by the idea of building systems in-house, versus being locked into a long-term vendor contract. Anthony explores the reason for this shift.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here